New Ph. Eur. Publication Schedule
Recommendation
6/7 October 2026
Dealing with different compendial methods
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The European Directorate for the Quality of Medicines & HealthCare (EDQM) has announced a major change of the European Pharmacopoeia (Ph. Eur.) publication schedule, starting with Issue 13.1.
Nine Months Implementation Period
Together with its transition to a fully online version, the Ph. Eur. is adopting a new publication schedule that will extend the period between publication and implementation dates from six to nine months.
This change will allow users more time to prepare for the upcoming modifications. Issue Ph. Eur. 13.1 will be published on the Ph. Eur. platform in April 2026. Its new and revised texts will take effect in January 2027.
The publication schedule for the current and upcoming issues of the Ph. Eur. is now available on the EDQM website and in Pharmeuropa.
For more information please see the announcement in the EDQM Newsroom Ph. Eur. publication schedule evolves to better meet users’ needs.
Related GMP News
17.08.2026Why Root Cause Analysis is the Key to efficient CAPA
17.08.2026EMA updates Guideline on implementing the Shortage Prevention Plan
17.08.2026FDA: Simplified Registration for U.S. Sites and Greater Complexity for Non-U.S. Sites
12.08.2026When Training Fails: FDA Warning Letters Highlight GMP Training Deficiencies in 2026
29.07.2026EU-GMP for Veterinary Medicinal Products: What will change in Switzerland?
15.07.2026Root Cause Analysis and CAPA: Two more Warning Letters issued to Companies in Europe